Detalhe da pesquisa
1.
Prognostic and biologic significance of long non-coding RNA profiling in younger adults with cytogenetically normal acute myeloid leukemia.
Haematologica
; 102(8): 1391-1400, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28473620
2.
Pyrimidine depletion enhances targeted and immune therapy combinations in acute myeloid leukemia.
JCI Insight
; 9(8)2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38646934
3.
BMX kinase mediates gilteritinib resistance in FLT3-mutated AML through microenvironmental factors.
Blood Adv
; 6(17): 5049-5060, 2022 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35797240
4.
Preclinical efficacy for a novel tyrosine kinase inhibitor, ArQule 531 against acute myeloid leukemia.
J Hematol Oncol
; 13(1): 8, 2020 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31992353
5.
TP-0903 is active in models of drug-resistant acute myeloid leukemia.
JCI Insight
; 5(23)2020 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33268594
6.
Interaction of imatinib with human organic ion carriers.
Clin Cancer Res
; 14(10): 3141-8, 2008 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18483382
7.
A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AML.
Nat Commun
; 10(1): 2189, 2019 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31097698
8.
Uncovering the Genomic Landscape in Newly Diagnosed and Relapsed Pediatric Cytogenetically Normal FLT3-ITD AML.
Clin Transl Sci
; 12(6): 641-647, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31350825
9.
Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology study.
Blood Adv
; 7(16): 4671-4675, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37603350
10.
Evaluation of artemisinins for the treatment of acute myeloid leukemia.
Cancer Chemother Pharmacol
; 77(6): 1231-43, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27125973
11.
Multikinase Inhibitors Induce Cutaneous Toxicity through OAT6-Mediated Uptake and MAP3K7-Driven Cell Death.
Cancer Res
; 76(1): 117-26, 2016 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26677977
12.
Contribution of OATP1B1 and OATP1B3 to the disposition of sorafenib and sorafenib-glucuronide.
Clin Cancer Res
; 19(6): 1458-66, 2013 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23340295
13.
Cisplatin-induced downregulation of OCTN2 affects carnitine wasting.
Clin Cancer Res
; 16(19): 4789-99, 2010 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20858838